SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-036358
Filing Date
2021-02-10
Accepted
2021-02-10 16:38:05
Documents
12
Period of Report
2021-02-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d116316d8k.htm   iXBRL 8-K 22537
  Complete submission text file 0001193125-21-036358.txt   141073

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nk-20210205.xsd EX-101.SCH 3066
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nk-20210205_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nk-20210205_pre.xml EX-101.PRE 10952
5 EXTRACTED XBRL INSTANCE DOCUMENT d116316d8k_htm.xml XML 3228
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
NantKwest, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 21614452
SIC: 2836 Biological Products, (No Diagnostic Substances)